肝细胞核增大Hepatocyte Karyomegaly · 肝 · 肝胆系统 · NTP ntp-0411

依据美国国家毒理学计划(NTP)Nonneoplastic Lesion Atlas 整理 · 中文译文与诊断建议 · 仅供科研使用,不用于临床诊断

一句话结论:尽管核增大(karyomegaly)主要是一种细胞核改变,但 Figure 1、Figure 2(箭头)显示肝细胞质和细胞核均增大。
诊断要点:虽然一定程度上的核增大在小鼠中经常可见,尤其是作为一种衰老性改变,但 Figure 1、Figure 2 中所示的核增大程度及伴随的肝细胞增大在亚慢性研究中的对照小鼠中通常不会见到。

病变描述

尽管核增大(karyomegaly)主要是一种细胞核改变,但 Figure 1、Figure 2(箭头)显示肝细胞质和细胞核均增大。该改变遍布肝小叶,但在小叶中央区更为显著。细胞核大小的增加与多倍体化(polyploidy)一致,但在这项亚慢性研究中,其严重程度显著大于在该年龄(约4.5个月)时所预期的程度。尽管在本研究中肝脏重量增加与肝细胞增大相关,但肝细胞增大的不均匀性加上核增大可将此改变与肝细胞酶诱导区分开来。核胞体增大(karyocytomegaly)的自发性发生在衰老啮齿类动物中常见,通常不与肝脏重量增加相关。这种衰老性改变常被称为多倍体化,在小鼠中比在大鼠中更为常见。

诊断与分级建议(NTP 共识)

虽然一定程度上的核增大在小鼠中经常可见,尤其是作为一种衰老性改变,但 Figure 1、Figure 2 中所示的核增大程度及伴随的肝细胞增大在亚慢性研究中的对照小鼠中通常不会见到。在此情况下,它是一种潜在的处理效应,应当予以诊断并给出严重程度分级。在慢性研究中通常不予记录,除非与同期对照相比存在明显的处理相关增加或减少。如果细胞质增大而细胞核不增大,则应使用术语“肥大(hypertrophy)”。

图谱

肝细胞核增大(肝)组织学图谱 1
图 1 · 肝细胞核增大 · 来源:NTP NNL Atlas
肝细胞核增大(肝)组织学图谱 2
图 2 · 肝细胞核增大 · 来源:NTP NNL Atlas

英文原文

展开 NTP 官方英文描述与建议

Comment:
Though karyomegaly is predominantly a nuclear change, Figure 1 and Figure 2 (arrow) show enlargement of both hepatocyte cytoplasm and nuclei. The change is throughout the hepatic lobule but is more prominent in the centrilobular areas. The increase in nuclear size is consistent with polyploidy, but in this subchronic study, the severity is significantly greater than one would expect at this age (~4.5 months). Although a liver weight increase was associated with enlarged hepatocytes in this study, the nonuniform hepatocyte enlargement plus the karyomegaly distinguish this change from hepatocyte enzyme induction. Spontaneous occurrence of karyocytomegaly is commonly seen in aging rodents and is not typically associated with increased liver weight. This aging change, often referred to as polyploidy, is more common in mice than in rats.

Recommendation:
While some degree of nuclear enlargement is frequently seen in mice, particularly as an aging change, the degree of nuclear enlargement and the accompanying enlargement of hepatocytes shown in Figure 1 and Figure 2 are not typically seen in control mice in prechronic studies. In this case it is a potential treatment effect and should be diagnosed and given a severity grade. It is typically not documented in chronic studies unless there is an obvious treatment-associated increase or decrease compared with concurrent controls. If the cytoplasm is enlarged but the nuclei are not, then the term “hypertrophy” should be used.

来源与引用

原始条目:https://ntp.niehs.nih.gov/atlas/nnl/hepatobiliary-system/liver/Hepatocyte-Karyomegaly

图谱总目录:NTP Nonneoplastic Lesion Atlas。 内容属美国联邦政府作品(公有领域),可引用;引用时请标注来源。

建议引用格式:NTP Nonneoplastic Lesion Atlas. Hepatocyte Karyomegaly (liver). LabSmart 中文版: https://www.labsmart.cn/ntp/liver-hepatocyte-karyomegaly.html

中文图谱总页(可展开对照全部 595 条):https://www.labsmart.cn/ntp-atlas.html#liver-hepatocyte-karyomegaly

卵圆细胞增生坏死张力性脂质沉积症星状细胞增生枯否细胞增生淀粉样物质